US Futures consolidating - Watch SNAP, BIIB, KO, COF, UAL, TXN, M


The S&P 500 Futures closed mixed yesterday as the Nasdaq 100 Index took a breather following a series of record closes

Stocks (1)

The S&P 500 Futures closed mixed yesterday, as the tech-heavy Nasdaq 100 Index (-119 points or -1.09% to 10833) took a breather following a series of record closes.

Later today, the National Association of Realtors will report June existing home sales (475 million units expected). The Federal Housing Finance Agency will post its house price index for May (+0.3% on month expected). 

European indices are on the downside as President Trump said that Covid-19 crisis is likely to get worse before it gets better.

Asian indices ended in the red except the Chinese CSI. This morning, official data showed that Australia's preliminary retail sales grew 2.4% on month in June (+16.9% on month in May).

WTI Crude Oil futures are under pressure. The American Petroleum Institute (API) reported that U.S. crude stockpiles built 7.5M bbl for the week ended July 16. Later today, the Energy Information Administration (EIA) will release official crude oil inventories data for the same week (-1.95M bbl expected).

Gold remains firm close to a nine-year high on sliding US dollar and hopes of stimulus measures.
Gold rose 17.43 dollars (+0.95%) to 1859.34 dollars.

The euro rose to its highest since October 2018 on euro zone recovery fund plan.
EUR/USD rose 51pips to 1.1578 while GBP/USD fell 28pips to 1.2703.

U.S. Equity Snapshot

Snap (SNAP), a camera and social media company, reported second quarter adjusted LPS of 0.09 dollar, below expectations, vs a LPS of 0.06 dollar a year ago, on revenue up 17% to 454 million dollars. Also, daily active user rose 4% quarter on quarter to 238 million, below estimates. Following that release, the stock was downgraded to "neutral" from "buy" at Guggenheim.

Source: TradingView, Gain Capital

Biogen Idec (BIIB), a pharmaceutical company, expects full year adjusted EPS between 34 dollars and 36 dollars, above current consensus, vs a previous forecast of 31.50-33.50 dollars. Separately, the company posted quarterly figures that beat estimates.

Coca-Cola (KO), the soft drinks giant, was upgraded to "overweight" from "equal weight" at Morgan Stanley.

Capital One Financial (COF), a diversified banking services firm, disclosed second quarter adjusted LPS of 1.61 dollar, worse than expected, vs an EPS of 3.37 dollars a year ago.

United Airlines (UAL), the transportation company, released second quarter adjusted LPS of 9.31 dollars, worse than anticipated, down from an EPS of 4.21 dollars a year ago, on net revenue of 1.5 billion dollars, above the consensus, down from 11.4 billion dollars last year.

Texas Instruments (TXN), a designer of semiconductors, announced second quarter EPS of 1.48 dollar, beating forecasts, up from 1.36 dollar a year ago on revenue of 3.2 billion dollars, exceeding estimates, down from 3.7 billion dollars in the previous year.

Macy's (M), the department store chain, was downgraded to "sell" from "neutral" at UBS.

Interactive Brokers (IBKR), a global proprietary trading business, reported second quarter adjusted EPS flat at 0.46 dollar, on sales up 31% to 539 million dollars. Both figures beat estimates.

Thermo Fisher Scientific (TMO), the scientific instruments maker, posted second quarter adjusted EPS up to 3.89 dollars from 3.04 dollars a year earlier, on sales up 9.5% to 6.92 billion dollars. Both top and bottom lines beat estimates.

Intuitive Surgical (ISRG), a developer of robotic systems for the medical industry, unveiled second quarter adjusted EPS of 1.11 dollar, exceeding forecasts, down from 3.25 dollars a year ago, on revenue of 852.1 million dollars, better than expected, down from 1.1 billion dollars a year earlier.

More from Equities


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.

Important Notice:

Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.